Netflix Finally Joins the M&A Game
Netflix is shifting from a “build, not buy” strategy to actively pursuing major acquisitions, from failed talks for Warner Bros. Discovery to bids for Roku and interest in Lionsgate.
Netflix is shifting from a “build, not buy” strategy to actively pursuing major acquisitions, from failed talks for Warner Bros. Discovery to bids for Roku and interest in Lionsgate.
PepGen has Buy ratings; DM1 drug data mixed, big 2026 results could drive huge upside from very low stock price.
The company plans to start with around 100 vehicles and scale to 17,000 within five years.
Shareholders get $18.50 per share. The company is expected to combine with Chemical Computing Group after closing. Deal expected to close in Q4 2026.
LongRange Capital will acquire the brand outside China, while Yum China buys the China operations. The deal ends years of underperformance for the pizza chain.
Edgewise shared encouraging Phase 2 CIRRUS-HCM results for EDG-7500, showing strong improvements in symptoms, biomarkers, and diastolic function across both types of HCM. Larger Phase 3 trials will be required before any approval.